Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
REDWOOD CITY, Calif., Aug. 14, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on August 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 10,199 shares of Nevro's common stock to four new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan and vests over a three-year period, subject to continued employment with Nevro through each vesting date.
加州雷德伍德城，2024年8月14日/美通社/--nevro(紐交所:NVRO)公佈，該公司的全球醫療器械公司正在爲慢性疼痛治療提供全面的、改變生命的解決方案。公司董事會的薪酬委員會於2024年8月7日宣佈，將授予四名新的非執行員工合計10,199股nevro公司的普通股的誘因限制性股票。每個獎勵都是根據nevro公司2023年誘因獎勵計劃授予的，並在三年內分期歸屬於持續與nevro公司僱傭的員工，視 vesting 日期而定。
Each award was granted as a material inducement to employment in accordance with the NYSE Listed Company Manual Rule 303A.08.
根據紐交所上市公司手冊規則303A.08，每個獎勵都是作爲物質引誘而授予的就業機會。
Internet Posting of Information
信息的互聯網發佈
Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at . The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.
Nevro定期在其網站投資者關係部分發布可能對投資者重要的信息。該公司鼓勵投資者和潛在投資者經常查看Nevro網站以獲取重要信息。關於Nevro
About Nevro
Nevro總部位於加利福尼亞州Redwood City，是一家全球醫療器械公司，專注於提供全面、能夠改變生活的治療方案，爲慢性疼痛的治療開創了標準。該公司創立的最初宗旨是幫助更多患有疼痛的病人，並發展出了其專有的10 kHz療法，這是一種以證據爲基礎的非藥物創新，已經在全球影響了超過115000名患者的生活。Nevro全面的HFX脊髓神經刺激 (SCS)平台包括Senza SCS系統和支持慢性軀幹和肢體疼痛及痛性糖尿病神經病變的治療的支持服務。
Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 115,000 patients globally. Nevro's comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy.
Nevro公司總部位於加利福尼亞雷德伍德城，是一家專注於爲慢性疼痛治療提供全面、改變生命的解決方案的全球醫療器械公司。該公司的起始目標是幫助更多遭受疼痛折磨的患者，並開發出了其專有的10 kHz療法，這是一種基於證據的非藥物創新，已經影響了全球超過115,000名患者的生活。Nevro的綜合HFX脊髓電刺激（SCS）平台包括Senza SCS系統和支持服務，用於治療軀幹和肢體慢性疼痛以及痛苦的糖尿病神經病變。
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in the SI joint fusion space, designed to meet the preferences of physicians and varying patient needs in order to improve outcomes and quality of life for patients.
Nevro最近爲患有慢性骶髂關節(SI關節)疼痛的患者添加了一項微創治療選擇，現在在SI關節融合領域提供最全面的產品組合，旨在滿足醫生的偏好和不同患者需求，以提高患者的治療效果和生活質量。
Senza, Senza II, Senza Omnia, and HFX iQ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's unique support services provide every patient with HFX Coach support throughout their pain relief journey and every physician with HFX Cloud insights for enhanced patient and practice management.
Senza,SenzaII,Senza Omnia和HFXiQ是唯一提供Nevro專有10 kHz療法的SCS系統。Nevro獨特的支持服務爲每個患者提供HFX Coach支持，貫穿他們的疼痛緩解旅程，爲每個醫生提供HFX Cloud見解，以增強患者和實踐管理。
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.
副總裁，投資者關係&nevro.com/專利.
To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
Nevro公司。LinkedIn, X, Facebook和Instagram.
Investor and Media Contact:
投資者和媒體聯繫人：
Angie McCabe
Vice President, Investor Relations & Corporate Communications
[email protected]
安吉·麥凱比
投資者關係和企業傳播副總裁
[email protected]
SOURCE Nevro Corp.
來源：Nevro公司。
譯文內容由第三人軟體翻譯。